Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid

Journal of Nuclear Medicine

Volumn 39, Issue 8 SUPPL., 1998, Pages 1320-1327

  Mäki, Maija T ^a   Haaparanta, Merja ^b   Nuutila, Pirjo ^a   Oikonen, Vcsa ^a   Luotolahti, Matti ^b   Eskola, Olli ^a   Knuuti, Juhani M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU PET CENTRE   (Finland)

Author keywords

Fluorine 18 fluoro 6 thia heptadecanoic acid; Free fatty acids; Muscle; Myocardium; PET

Indexed keywords

FATTY ACID; FLUORINE 18; FLUORO 6 THIAHEPTADECANOIC ACID F 18; INSULIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; HEART MUSCLE METABOLISM; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; INSULIN BLOOD LEVEL; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CORONARY DISEASE; FASTING; FATTY ACIDS; FEASIBILITY STUDIES; FLUORINE RADIOISOTOPES; HEART; HUMANS; INSULIN; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOCARDIUM; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031857333     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Neely J, Morgan H. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annii Rev Physiol 1974:36:413-459.
2. Opie LH. Owen P, Ricmersma R. Relative rates of oxidation of glucose and free fatty acids by ischacmic and non-ischaemic myocardium after coronary artery ligation in the dog. EurJ Clin Invest 1973;19:419-435.
3. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 1994:19:62-113.
4. Dagenais G. Tancredi R, Zierler K. Free fatty acid oxidation by forearm muscle at res.. and evidence for an intramuscular lipid pool in the human forearm. J Clin Inve.'l 1976:58:421-431.
5. Kelley D, Mokan M, Simoneau J-A, Mandarine L. Interaction between glucose anj free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993:92:91-98.
6. Kelley D. Simoneau J-A. Impaired free fatty aeid utilization by skeletal muscle i i non-insulin-dependent diabetes mellitus. J Clin Invest 1994:94:2349-2356.
7. Sehelbert H. Schwaiger M. PET studies of the heart. In: Phelps M. Marizziotta .i. Scheiben H. eds. Positron emission tomograph}' and aiitortidiographv: princif>k'-s anJ applications for the brain and heart. New York: Raven Press; 1986:599-616.
8. Fain J. Kovacev V, Scow R. Antilipolytic effect of insulin in isolated fat cells of the rat. Endocrinology- 1966:78:773-778.
9. Barrett E. Schwartz R. Francis C, Zaret B. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984:74:1073 1079.
10. Rändle P, Garland P, Hales C, Newsholme E. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963: 1:785-789.
11. Bergmann S. Weinheimer C, Markham J, Herrcro P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996:37:1723-1730.
12. Capaldo B, Napoli R, Di Marino L. Pieardi A. Riceardi G. Sacea L. Quantitation o' forearm glucose and free fatty acid (FFA) disposal in normal subjects and type I diabetic patients: evidence against an essential role for FFA in the pathogenesis oinsulin resistance. J Clin Endocrinol Metab 1988:67:893 898.
13. Eiedtke J. Alterations of carbohydrate and lipid metabolism in the acutely ischémie heart. Prog Cardim-asc Dis 1981:23:321-336.
14. Tamaki N. Kawamoto M, Takahashi N, et al. Assessment of myocardial fatty acic metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease. Am Heart J 1993:125:702 710.
15. DeGrado T. Coenen H. Stöcklin G. 14 (R,S)-[lsF]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty aeids. J Nucl Med 1991:32:1888-1896.
16. Rosen P. Reinauer H. Inhibition of carnitine palmitoyltransferase by phenylalkyloxiraneearboxylic acid and its influence on lipolysis and glucose metabolism in isolated perfused hearts of streptozotocin-diabetic rats. Metaholism 1984:33:177-185.
17. hbert A. Herzog H. Stöcklin G. et al. Kinetics of 14(R.S)-fluorinc-18-fluoro-6-thiaheptadecanoic acid in normal human hearts at rest, during exercise and alter dipyridamole injection. J Nuel Mcd 1994:35:51 56.
18. Altehoefer C. vom Dahl J, Bares R. Stocklin GL. Bull U. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch bloc assessed with PET. ./ \iicl Mal 1995;36:2056-2059.
19. Sehultz G, vom Dahl J, Kaiser H. et al. Imaging of β-oxidation by static PET with 14(R.S)-[IKF]-fluoro-6-thiaheptadecanoic acid (FTHA) in patients with advanced coronary heart disease: a comparison with 'FDG PET and '''Tc-MIBI SPET. ,Vi/t7 Met! Commun 1996:17:1057 1064.
20. Knuuti MJ. Nuutila P. Ruotsalainen U. et al. Huglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilisation during positron emission tomography. J Nucl Mcü 1992:33:1255 1262.
21. DeFronzo R. Tobin J. Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979:237:E2I4 E223.
22. Clark J. Crouzcl C, Meyer G, Strijckmans K. Current methodology for o.xygeu-15 production for clinical use. Appl Radiât l.mt 19X7:38:597 600.
23. Crouzel C. Clark J, Brihaye C, ct al. Radiochemistry automation for PET. In: Stöcklin Ci, Pike V, eds. RuiliopharmaCL'iiticul for positron t'ini.'
24. DeGrado T. Synthesis of 14(R.S)-[IKF]fluoro-6-thia-heptadccanoic acid (F'lllA). ./ Lab Cumpii Radiopharm 1991:24:889 995.
25. Maki M, Euotolahti M. Nuutila P. et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996:93:1658 1666.
26. Raitakan M. Knuuti J. Riiotsalainen U. et al. Insulin increases blood volume in human skeletal muscle:studies using [lriO]CO and positron emission tomography. Am J P/n-.v/W 1995;269:L100() L1005.
27. Patlak C'S, Blasberg RG. Cïraphical evaluation of blood-to-brain transfer constants from multipletime uptake data. Generali/ations. J Cercb Blood /-'low Metab 1985:5: 584 590.
28. Schiller N, Shah P, C'rawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358367.
29. Kadish A, Little R, Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968; 14:116-131.
30. Marbach E. Weil M. Rapid enzymatic measurement of blood lactate and pymvate. Clin Chou 1967:13:314-325.
31. Fox K. Abendschein D. Ambos H, Sobel B, Bergmann S. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically. Circ Res !985;57:232-243.
32. van tier Vusse G, Rocrnen Th, Prinzen l;. Coumans W. Reneman R. Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischémie conditions. Cin- Rc.\ 1982:50:538 546.
33. Wisneski J. (iertz F. Neese R. Mayr M. Myocardial metabolism of free fatty acids. Studies with I40-labeled substrates in humans. J Clin Invest 1987:79:359-366.
34. Nell is S. Licdtke A, Renstom B. Fatty acid kinetics in aerobic myocardium: characteristics of tracer carbon entry and washout and influence of myocardial demand. ,/ \ticl Mcd 1992:33:1864 1874.